107
Participants
Start Date
June 30, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Apidra
Subjects on this treatment arm will receive Apidra insulin for their bolus doses, with doses optimized individually to achieve glycemic targets at daily medical rounds with their cabin physicians.
Humalog
Subjects on this treatment arm will receive Humalog insulin for their bolus doses, with doses optimized individually to achieve glycemic targets at daily medical rounds with their cabin physicians.
Novolog
Subjects on this treatment arm will receive Novolog insulin for their bolus doses, with doses optimized individually to achieve glycemic targets at daily medical rounds with their cabin physicians. (NOTE: This arm was only for one year of the study which was the 2012 camp session.)
Camp Winona, DeLeon Springs
Collaborators (1)
Sanofi
INDUSTRY
University of Florida
OTHER